Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmenopausal hormone-replacement therapy and cardiovascular risk

F Krempler1, S M Soyal, W Patsch

  • 1Department of Medicine, Krankenhaus Hallein, Austria.

Annals of Medicine
|April 1, 1995
PubMed
Summary

Postmenopausal estrogen replacement therapy may lower risks of atherosclerotic disease. Further research is needed to confirm benefits and optimize treatment, especially regarding progestogen effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach.

Diabetes & metabolism·2018
Same author

Gender- and site-specific differences of colorectal neoplasia relate to vitamin D.

Alimentary pharmacology & therapeutics·2014
Same author

Salzburg Skiing for the Elderly Study: changes in cardiovascular risk factors through skiing in the elderly.

Scandinavian journal of medicine & science in sports·2011
Same author

Glucose homeostasis and cardiovascular disease biomarkers in older alpine skiers.

Scandinavian journal of medicine & science in sports·2011
Same author

Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia.

Journal of internal medicine·2011
Same author

Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans.

Diabetologia·2010

Area of Science:

  • Cardiovascular disease
  • Endocrinology
  • Public health

Background:

  • Observational studies suggest postmenopausal estrogen replacement therapy (ERT) reduces atherosclerotic disease risk.
  • Evidence for ERT's cardioprotective effects is limited due to a lack of randomized controlled trials.
  • Future placebo-controlled trials may be infeasible, necessitating alternative study designs to mitigate bias.

Purpose of the Study:

  • To evaluate the incomplete evidence for ERT's cardioprotective effects.
  • To explore alternative study designs for future research on ERT and cardiovascular health.
  • To investigate optimal ERT dosing, administration, and the impact of progestogens.

Main Methods:

  • Review of case-control and cohort studies on ERT and atherosclerotic disease.

Related Experiment Videos

  • Discussion of limitations in current evidence, particularly the absence of randomized trials.
  • Proposal for future research designs to address selection bias and mechanistic insights.

    • Main Results:

    • Existing evidence supports a hypothesis of reduced atherosclerotic disease risk with postmenopausal ERT.
    • The cardioprotective effect of ERT requires confirmation through rigorous study designs.
    • Optimal ERT strategies and progestogen influence on cardiovascular outcomes remain undetermined.

    Conclusions:

    • Postmenopausal ERT shows potential for reducing atherosclerotic disease, but definitive evidence is lacking.
    • Future research must address methodological challenges, including selection bias and the role of progestogens.
    • Understanding ERT's impact on lipoprotein metabolism and hemostasis is crucial for elucidating its cardiovascular effects.